GlobeNewsWire
05 Jul 2026, 17:00 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
ADMA Biologics is facing a securities fraud class action lawsuit alleging channel stuffing and undisclosed related party transactions. — Allegations of financial manipulation and fraudulent revenue reporting typically lead to severe loss of investor confidence and potential regulatory penalties.
-0.80A Culper Research report alleges ADMA Biologics reported 20% growth in 2025 while real growth was actually -3%. — A significant discrepancy between reported and actual growth suggests a fundamental misrepresentation of the company's financial health.
-0.70The lawsuit alleges that ADMA Biologics lacked adequate internal controls over its business operations. — Poor internal controls increase the risk of future financial misstatements and operational instability.
-0.50Continue reading
6 related stories
Top 3 movers · tap to explore
ADMA Biologics' stock price dropped 29.1% over two trading days following the release of the Culper Research report. — The price drop confirms the market's immediate negative reaction to the fraud allegations, establishing a downward trend.
-0.30Which stocks this story touches
The company is facing a securities fraud class action lawsuit following allegations of channel stuffing and undisclosed related party transactions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
4h ago
